[go: up one dir, main page]

ECSP077130A - Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos - Google Patents

Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos

Info

Publication number
ECSP077130A
ECSP077130A EC2007007130A ECSP077130A ECSP077130A EC SP077130 A ECSP077130 A EC SP077130A EC 2007007130 A EC2007007130 A EC 2007007130A EC SP077130 A ECSP077130 A EC SP077130A EC SP077130 A ECSP077130 A EC SP077130A
Authority
EC
Ecuador
Prior art keywords
treatment
aminopiridines
nause
diciano
fenil
Prior art date
Application number
EC2007007130A
Other languages
English (en)
Inventor
Ulrich Rosentreter
Thomas Kraemer
Nicole Diedrichs
Thomas Krahn
Wolfgang Thielemann
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of ECSP077130A publication Critical patent/ECSP077130A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere al uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas de fórmula (I) para la preparación de un medicamento para la profilaxis y/o tratamiento de náuseas y vómitos.
EC2007007130A 2004-07-06 2007-01-05 Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos ECSP077130A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004032651A DE102004032651A1 (de) 2004-07-06 2004-07-06 Verwendung von substituierten 2-Thio-3,5-dicyano-4-phenyl-6-aminopyriden bei der Behandlung von Übelkeit und Erbrechen

Publications (1)

Publication Number Publication Date
ECSP077130A true ECSP077130A (es) 2007-02-28

Family

ID=34970906

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007130A ECSP077130A (es) 2004-07-06 2007-01-05 Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos

Country Status (18)

Country Link
US (1) US7709504B2 (es)
EP (1) EP1765343B1 (es)
JP (1) JP2008505139A (es)
KR (1) KR20070041561A (es)
CN (1) CN101014342A (es)
AT (1) ATE446753T1 (es)
AU (1) AU2005259506A1 (es)
BR (1) BRPI0513149A (es)
CA (1) CA2572990A1 (es)
DE (2) DE102004032651A1 (es)
EC (1) ECSP077130A (es)
ES (1) ES2333805T3 (es)
IL (1) IL180551A0 (es)
MA (1) MA28707B1 (es)
MX (1) MX2007000224A (es)
NO (1) NO20070608L (es)
RU (1) RU2007104234A (es)
WO (1) WO2006002823A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110747A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung
DE102004042607A1 (de) * 2004-09-03 2006-03-09 Bayer Healthcare Ag Substituierte Phenylaminothiazole und ihre Verwendung
DE102006042143A1 (de) * 2006-09-08 2008-03-27 Bayer Healthcare Aktiengesellschaft Neue substituierte Bipyridin-Derivate und ihre Verwendung
DE102006056739A1 (de) * 2006-12-01 2008-06-05 Bayer Healthcare Ag Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
DE102006056740A1 (de) * 2006-12-01 2008-06-05 Bayer Healthcare Ag Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
DE102007035367A1 (de) 2007-07-27 2009-01-29 Bayer Healthcare Ag Substituierte Aryloxazole und ihre Verwendung
DE102007036076A1 (de) 2007-08-01 2009-02-05 Bayer Healthcare Aktiengesellschaft Dipeptoid-Produgs und ihre Verwendung
DE102007061764A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellierte Cyanopyridine und ihre Verwendung
DE102007061763A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Substituierte azabicyclische Verbindungen und ihre Verwendung
DE102008013587A1 (de) * 2008-03-11 2009-09-17 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
US8791146B2 (en) * 2008-05-29 2014-07-29 Bayer Intellectual Property Gmbh 2-alkoxy-substituted dicyanopyridines and their use
DE102008062567A1 (de) 2008-12-16 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) * 2009-01-29 2010-08-05 Bayer Schering Pharma Aktiengesellschaft Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
DE102010030688A1 (de) 2010-06-30 2012-01-05 Bayer Schering Pharma Aktiengesellschaft Substituierte Dicyanopyridine und ihre Verwendung
US20120058983A1 (en) 2010-09-02 2012-03-08 Bayer Pharma Aktiengesellschaft Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
SMT202200134T1 (it) 2018-03-08 2022-05-12 Incyte Corp Composti di amminopirazindiolo come inibitori di pi3k-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
WO2025038781A1 (en) * 2023-08-15 2025-02-20 Lucy Therapeutics, Inc. Adenosine ligands for the treatment of neurological disorders or chronic heart failure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0105469D0 (en) * 2001-03-06 2001-04-25 Glaxo Group Ltd Medicaments
DE10115922A1 (de) * 2001-03-30 2002-10-10 Bayer Ag Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10134481A1 (de) 2001-07-16 2003-01-30 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
DE10238113A1 (de) * 2001-12-11 2003-06-18 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
NZ534801A (en) * 2002-02-19 2006-04-28 Cv Therapeutics Inc Partial and full agonists of A1 adenosine receptors

Also Published As

Publication number Publication date
JP2008505139A (ja) 2008-02-21
BRPI0513149A (pt) 2008-04-29
CA2572990A1 (en) 2006-01-12
EP1765343A1 (de) 2007-03-28
KR20070041561A (ko) 2007-04-18
MX2007000224A (es) 2007-06-15
US7709504B2 (en) 2010-05-04
EP1765343B1 (de) 2009-10-28
DE502005008416D1 (de) 2009-12-10
WO2006002823A1 (de) 2006-01-12
NO20070608L (no) 2007-02-01
ES2333805T3 (es) 2010-03-01
DE102004032651A1 (de) 2006-02-16
ATE446753T1 (de) 2009-11-15
MA28707B1 (fr) 2007-06-01
AU2005259506A1 (en) 2006-01-12
US20080249133A1 (en) 2008-10-09
CN101014342A (zh) 2007-08-08
RU2007104234A (ru) 2008-08-20
IL180551A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
CY1115713T1 (el) Παραγωγα ακρυλαμιδιου ως αντιβιοτικοι παραγοντες
NO20070323L (no) Organiske forbindelser
ECSP088367A (es) Derivados de bifenilo y su uso en el tratamiento de la hepatitis c
MX2007005933A (es) Compuestos de acetamida como fungicidas.
UY29479A1 (es) Inhibidores de adn-pk
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
EA200702643A1 (ru) Антитела, связывающие tweak
NO20071095L (no) Hittil ukjente tiofenderivater
TW200637837A (en) Fungicides
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
CR8559A (es) Pirazolopirimidinas
ATE483000T1 (de) Naphtalin-amidin-imide
SG148179A1 (en) Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
IN2012DN02609A (es)
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
DE502006004472D1 (de) Organische elektrolumineszenzvorrichtungen
EA201270630A1 (ru) Гетероциклические сетр ингибиторы
CR9058A (es) Derivados de indol como inhibidores de la adenilato ciclasa soluble
EA200801414A1 (ru) Кальцилитические соединения
CY1109038T1 (el) Μη στεροειδεις ρυθμιστες υποδοχεα γλυκοκορτικοειδων
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
NO20063293L (no) Farmasoytiske forbindelser
EA200702290A1 (ru) Мотилидные соединения